(Q40299705)

19 September 2017

title

Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells (English)

1 reference

19 September 2017

1 reference

4

Vadim N Gladyshev

1 reference

19 September 2017

Min-Hyuk Yoo

1

1 reference

19 September 2017

Xue-Ming Xu

series ordinal

2

1 reference

19 September 2017

Bradley A Carlson

series ordinal

3

1 reference

19 September 2017

Dolph L Hatfield

series ordinal

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

25 March 2006

1 reference

Journal of Biological Chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

19

1 reference

19 September 2017

page(s)

13005-13008

1 reference

Characterization of mammalian selenoproteomes.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Human selenoproteins at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Mammalian selenium-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Selenium in cancer prevention: a review of the evidence and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Role of osteopontin in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Redox-dependent transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Physiological functions of thioredoxin and thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C600012200

21 January 2018

Identifiers

DOI

10.1074/JBC.C600012200

1 reference

19 September 2017

1 reference